Researchers have discovered that a protein called Runx3 programs killer T cells to establish residence in tumours and infection sites. [ + ]

Australian epilepsy researchers have used a mobile, brain-inspired processor to bring personalised seizure prediction a step closer to a reality. [ + ]

Queensland researchers have found that 38% of cancer deaths in Australia, or 16,700 each year, could potentially be avoided — mostly through lifestyle changes. [ + ]

Merck has entered into an agreement with Avanti Polar Lipids to be the exclusive multinational distributor of the latter's research lipids portfolio outside of the United States. [ + ]

Scientist and angel investor Dr Jay Hetzel has been appointed chairman of UniQuest, The University of Queensland's commercialisation company. [ + ]

Australian scientists have invented a gel that seals wounds and stops bleeding — both internally and externally — within 60 seconds. It sends signals to the body to start repairing the wound — at twice the regular speed. [ + ]

ANSTO and Swedish company Quintus Technologies have formed a new technology partnership that will play a crucial role in treating waste arising from nuclear medicine production. [ + ]

Person-to-person genetic differences may undercut the efficacy of the gene editing process or, in more rare cases, cause a potentially dangerous off-target effect, warn researchers. [ + ]

The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData. [ + ]

Belgian researchers have labelled the protein Caveolin-1 as a high-potential pursuit in the fight against cancer, describing the 'anti-metastatic surveillance' role of the protein for the first time. [ + ]

You may be impressed to hear that there are iron objects in existence today that date back to the Bronze Age, but their meteorite origin is even more astonishing. [ + ]

Researchers, headed by Professor Jens Nielsen at Chalmers University of Technology, have successfully mapped out the complex metabolism of yeast cells. [ + ]

A novel compound may restore immune response in patients with melanoma, according to a study presented at the ESMO Immuno Oncology Congress 2017 held in Geneva, Switzerland. [ + ]

Animal studies undertaken at UTHealth have shown that the two seaweed extracts — known as fucoidans — have reduced tumour growth in select cancers and significantly improved the effectiveness of the common chemotherapy drug tamoxifen. [ + ]

Supercomputer simulations have revealed the role of transport proteins called efflux pumps in creating drug resistance in bacteria — a breakthrough that could help improve drugs' effectiveness against life-threatening diseases and restore the efficacy of defunct antibiotics. [ + ]